The discovery of sulfoxaflor [N-[methyloxido[1-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-λ(4)-sulfanylidene] cyanamide] resulted from an investigation of the sulfoximine functional group as a novel bioactive scaffold for insecticidal activity and a subsequent extensive structure-activity relationship study. Sulfoxaflor, the first product from this new class (the sulfoximines) of insect control agents, exhibits broad-spectrum efficacy against many sap-feeding insect pests, including aphids, whiteflies, hoppers, and Lygus, with levels of activity that are comparable to those of other classes of insecticides targeting sap-feeding insects, including the neonicotinoids. However, no cross-resistance has been observed between sulfoxaflor and neonicotinoids such as imidacloprid, apparently the result of differences in susceptibility to oxidative metabolism. Available data are consistent with sulfoxaflor acting via the insect nicotinic receptor in a complex manner. These observations reflect the unique structure of the sulfoximines compared with neonicotinoids.
Addition of alcohols to solutions of
dipyrido[2,3-a:3‘,2‘-i]carbazole
leads to fluorescence quenching and to
the appearance of a new, strongly red-shifted fluorescence band.
This new band is interpreted in terms of
excited state double proton transfer in dipyridocarbazole:alcohol
complexes. This conclusion is supported
by the results of transient picosecond absorption studies and the
calculations performed for the intitial and
tautomeric forms. Two different precursors of the tautomer are
identified: in one of them, the reaction
occurs through a barrier, while in the other, phototautomerization
proceeds even at low temperatures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.